Home › NDC Lookup › RxCUI directory › RxCUI 1808189

Chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML Oral Solution — RxCUI 1808189

RxNorm drug concept · Semantic clinical drug
RxCUI 1808189 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1808189
Official nameChlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlophedianol HCl 12.5 MG / pyrilamine maleate 25 MG per 30 ML Oral Solution; chlophedianol HCl 12.5 MG / pyrilamine maleate 25 MG in 30 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Chlophedianol hydrochloride 0.417 MG/ML / pyrila... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML Oral Solution RxCUI 1808189

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Chlophedianol 21254
    • Pyrilamine 9009
    • Chlophedianol / pyrilamine 1429359
    • Chlophedianol hydrochloride 1014329
    • Pyrilamine maleate 82091
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vanacof AC 1940455
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlophedianol / pyrilamine Oral Solution 1429358
    • Chlophedianol hydrochloride / pyrilamine maleate Oral Solution 2649267
    • Chlophedianol / pyrilamine Oral Liquid Product 1429356
    • Chlophedianol / pyrilamine Oral Product 1429357
    • Chlophedianol hydrochloride / pyrilamine maleate Oral Liquid Product 2662534
    • Chlophedianol hydrochloride / pyrilamine maleate Oral Product 2660913
    • Chlophedianol / pyrilamine Oral Solution [Vanacof AC] 1940457
    • Chlophedianol hydrochloride / pyrilamine maleate Oral Solution [Vanacof AC] 2657704
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Chlophedianol hydrochloride 0.417 MG/ML 1808187
    • Pyrilamine maleate 0.833 MG/ML 1808188
    • Chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML Oral Solution [Vanacof AC] 1940460
    • Chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML [Vanacof AC] 1940456

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chlophedianol hydrochloride 0.417 MG/ML SCDC · 1808187
  • Pyrilamine maleate 0.833 MG/ML SCDC · 1808188
  • Chlophedianol / pyrilamine Oral Solution SCDF · 1429358
  • Chlophedianol hydrochloride / pyrilamine maleate Oral Solution SCDFP · 2649267
  • Chlophedianol / pyrilamine Oral Liquid Product SCDG · 1429356
  • Chlophedianol / pyrilamine Oral Product SCDG · 1429357
  • Chlophedianol hydrochloride / pyrilamine maleate Oral Liquid Product SCDGP · 2662534
  • Chlophedianol hydrochloride / pyrilamine maleate Oral Product SCDGP · 2660913

Brand-Name Concepts

  • Chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML Oral Solution [Vanacof AC] SBD · 1940460
  • Chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML [Vanacof AC] SBDC · 1940456
  • Chlophedianol / pyrilamine Oral Solution [Vanacof AC] SBDF · 1940457
  • Chlophedianol hydrochloride / pyrilamine maleate Oral Solution [Vanacof AC] SBDFP · 2657704
  • Vanacof AC Oral Liquid Product SBDG · 1940458
  • Vanacof AC Oral Product SBDG · 1940459
  • Vanacof AC BN · 1940455

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1808189 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58809-0925-08 237 mL in 1 BOTTLE (58809-925-08) TexaClear Kids Allergy GM Pharmaceuticals, Inc. 2016-06-15
Observed labelers: GM Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.